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A B S T R A C T   
Gastrointestinal ischemia/reperfusion (I/R) injury occurs in multiple clinical situations. We examined effects of 
zinc carnosine (ZnC), a health food supplement claimed to possess gastrointestinal supportive activity, on I/R 
injury. AGS, RIE and Caco-2 cells exposed to hypoxia/normoxia (H/N) reduced cell viability by 50%. ZnC given 
prior- or during-hypoxia improved survival by 50–70% (p < 0.01) and truncated increase in transepithelial 
permeability (HRP passage) by 50% whereas carnosine or ZnSO4 were ineffective. Induction of mesenteric I/R 
injury in mice caused severe jejunal mucosal and lung injury, increased lipid peroxidation (MDA), inflammatory 
infiltration (MPO) and circulating LPS and cytokines. ZnC (58 mg/kg/day, oral 7 days) reduced injury by 50%, 
reduced pro-apoptotic Caspase 3, 9 and Baxα, increased Bcl2 and Hsp70, and maintained tight junction ZO1 and 
Claudin1 levels (all p < 0.01 vs I/R alone). ZnC shows benefit over using zinc salt or carnosine. Oral ZnC may be 
a useful clinical approach for I/R injury.   
1. Introduction 
Chronic gastrointestinal ischemia/reperfusion (I/R) injury is 
involved in multiple clinical situations, such as neonatal necrotizing 
enterocolitis (Gregory, Deforge, Natale, Phillips, & Van Marter, 2011), 
radiation enteritis, chronic mesenteric ischemia (especially in the 
elderly) (Mensink, Moons, & Kuipers, 2011), cardiopulmonary disease 
and other conditions that reduce systemic blood flow such as shock 
states (Sastry et al., 2014), and intestinal transplantation or subsequent 
rejection (Lenaerts et al., 2013). In addition to local tissue injury, remote 
organs may be damaged by an excess inflammatory response resulting 
from release of inflammatory mediators and activation of leukocytes, 
due to the post-ischemic gut serving as a priming bed for circulating 
polymorphonuclear cells (Hassoun et al., 2012; Moore et al., 1994) 
The combination of localized injury with an excessive systemic in-
flammatory response can result in a breakdown of gut mucosal integrity, 
increased gut permeability and leakage of luminal bacteria and other 
contents into the circulation resulting in repeated septicemic episodes. 
Current therapeutic options for chronic IR injury are limited. When 
possible, revascularization of partially occluded vessels provides relief, 
but if the underlying cause is not vascular occlusion or if surgery is not 
an option, current medicinal options of proton pump inhibitors, vaso-
dilators, anticoagulation and antimicrobials have limited benefit (Eltz-
schig, 2004, 2014; Mensink et al., 2011) 
There is currently a demand by the general public for more natural 
types of products, particularly for prolonged usage. Natural products 
with pharmaceutical activity are sometimes termed nutraceuticals (from 
nutrition and pharmaceuticals). Although artificially produced, zinc 
carnosine (ZnC) falls into this category and is freely available via the 
internet or through health food shops. ZnC is an artificially produced 
derivative of carnosine, where zinc and carnosine, a dipeptide 
comprising β-alanine and L-histidine are linked in a one-to-one ratio to 
provide a polymeric structure. We considered ZnC had potential value 
for I/R injury based on the findings that (A) Carnosine is naturally 
present in long-living cells such as muscle and nerves, where it probably 
has a role as an antioxidant (Boldyrev, 2005). (B) ZnC stimulates several 
aspects of gut mucosal integrity including increasing cell migration and 
proliferation (Mahmood et al., 2007). (C) A clinical trial of oral ZnC 
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showed it prevented the rise in gut permeability caused by clinical doses 
of the NSAID indomethacin (Mahmood et al., 2007). 
In the current series of studies, we examined whether ZnC adminis-
tration influences gut I/R-induced injury and the likely molecular 
pathways involved in any effects seen. We also examined whether the 
macromolecular structure of ZnC was relevant it mediating its activity 
by examining its individual sub-components (tested as zinc sulphate and 
L-carnosine alone or in combination) in their ability to reduce Hypoxia 
(Ischemia)/ Normoxia (Reperfusion) (H/N) injury. 
2. Materials and methods 
Chemicals were purchased from Sigma (Poole, Dorset) unless 
otherwise stated. 
2.1. Cell lines 
Caco-2 is derived from colorectal adenocarcinoma of 72-year-old 
male (ATCC) and exhibits tight junctions and desmosomes between 
adjacent cells and grows as polarized monolayers (Fogh, Fogh, & Orfeo, 
1977). AGS is derived from gastric adenocarcinoma of a 54-year-old 
female (Barranco, Townsend, & Casartelli, 1983) (ATCC), RIE1 is a 
spontaneously immortalized rat intestinal epithelial cell line (Blay & 
Brown, 1984) (ATCC). Cells were grown in DMEM or RPMI medium 
dependent on cell line. 
2.2. Study 1. Effect of ZnC on cell survival following hypoxia (Ischemia)/ 
normoxia (Reperfusion) (H/N) 
1A: Dose response study: To examine the effect of ZnC on H/N- 
induced cell injury in vitro, cells were set up in 96 well plates to 
70–80% confluence and pre-incubated in serum free medium (SFM) 
containing glucose, with or without 10, 50, 100 or 200 μM ZnC (Xsto 
Solutions, New Jersey, USA) for 1 h (i.e. ZnC pre-treatment). The me-
dium was subsequently replaced with SFM without glucose and placed 
in the hypoxia incubator (2% oxygen) for 4 h. At the end of the hypoxia 
period, medium was replaced with SFM containing glucose for 24 h at 
normoxia for the reperfusion period. All treatments were duplicated in a 
second set of identical plates under normoxic conditions throughout the 
same test period as controls. 
1B: Efficacy of ZnC given pre-, during- or post-hypoxic period. We 
compared the potential benefit of giving ZnC prior to, during or 
following the hypoxic period. Cells were pre-treated with 100 μM ZnC 
for the 1 h before hypoxia (Pre), at the time of the start of hypoxic period 
(During, 2% oxygen) or added at the start of the return to normoxia 
stage (Post). The dose of 100 μM ZnC was chosen based on the optimal 
dose obtained from study 1A. To assess the effect of zinc and carnosine 
alone or in combination additional cells were incubated as above in an 
equivalent concentration of ZnSO4 (100 μM), L-carnosine (100 μM) or 
ZnSO4 (100 μM) + L-carnosine (100 μM). Cell Viability (MTT assay) and 
cell damage (LDH assay) were then assessed. 
2.2.1. Cell viability (MTT) and lactate dehydrogenase (LDH) assays 
Cell viability following H/N was assessed using a commercial MTT 
assay following manufacturer’s instructions (Marshall, Goodwin, & 
Holt, 1995). The principal of the assay is that viable cells contain NAD 
(P)H-dependent oxidoreductase enzymes which reduce the MTT re-
agent to formazan which can be measured spectrophotometrically. Cell 
damage was also assessed using the activity of LDH released into the cell 
culture medium. LDH activity was determined using a Pierce LDH 
Cytotoxicity Assay Kit (Thermo Fisher Scientific, Hemel Hempstead, UK) 
following manufacturer’s instructions. For both assays results are 
expressed as percentage of the equivalent normoxic control, as 
mean ± SEM of six wells. 
2.3. Study 2. Effect of ZnC on transepithelial permeability in cells exposed 
to H/N 
Cells were grown to confluent monolayers in 6 well transwell plates. 
We examined the effect of 100 μM ZnC pre-treatment on transepithelial 
permeability induced by 1 h of hypoxia followed by 24 h of normoxia 
using Caco-2, polarising colonic adenocarcinoma cells. Timings were 
chosen based on preliminary studies showing that these conditions 
result in a five to six-fold increase in horse radish peroxidase (HRP) 
permeability but do not affect cell death, allowing a continuous mono-
layer to be maintained. The dose of 100 μM ZnC was chosen based on the 
results from study 1 examining cell viability. Two different published 
methods were used to determine changes in permeability, one followed 
change in transepithelial electrical resistance (TEER) and the other 
analysed the passage of horseradish peroxidase (HRP) across the 
epithelial layer. HRP (type II) is a nondigestible macromolecular protein 
(MW = 44 kD) and has previously been used as a tracer in evaluation of 
epithelial permeability (Davison, Marchbank, March, Thatcher, & 
Playford, 2016). Measurements were taken in triplicate from 4 wells per 
treatment. Results are expressed as mean ± SEM. 
2.4. Study 3. Effect of ZnC on gut and distant organ injury in response to 
small intestinal I/R in mice 
2.4.1. Animal experiments 
All animal experiments were approved by local animal ethics com-
mittees (Queen Mary University of London’s Animal Welfare and Ethical 
Review Board), performed at Queen Mary University of London, Barts & 
The London School of Medicine and Dentistry and covered by the 
appropriate project licences under the Home Office Animals Procedures 
Acts, 1986. Experiments were performed under terminal anethesia using 
ketamine and xylaxine. 
2.4.2. I/R model 
Male CD-1 mice (30–32 g) were randomly assigned to one of four 
groups (N = 8–11 per group); (A) I/R alone, (B) I/R + ZnC (58 mg/kg/ 
day, in drinking water, 7 days pre-treatment) (C) Sham group animals, 
that underwent a laparotomy but no clamping of the SI. The 7-day 
duration of ZnC pre-treatment was based on our previous work exam-
ining the effect of ZnC on NSAID gut injury (Mahmood et al., 2007). All 
animals entered into the protocols survived the entire procedure and 
were included in the analyses. 
Method of induction of I/R: Mice were anesthetised with ketamine 
(100 μg/g, ip) and xylazine (10 μg/g, ip). To induce ischemia, the 
midsection of SI along with its associated mesenteric vessels, comprising 
approximately the region 30–75% of total length (where entire length is 
defined as 100%, with proximal duodenum starting at 0% and end of SI 
as 100% distance) was clamped using non-traumatic surgical clamps 
(UK Quality Instruments, Ramsgate, Kent) for 30 min, followed by 
removal of the clamp and 3 h of reperfusion. Visual inspection of the 
previously clamped region of the gut was performed at the time of clamp 
removal to check that the segment became reperfused. 
At the end of the study, under terminal anaesthesia, mice were killed 
by cervical dislocation and blood collected by cardiac puncture (approx. 
1 ml). For intestinal tissues, the position of the various samples was 
defined by expressing its harvest site as a percentage total length at 50% 
and 90% small intestinal distance and can be considered as equivalent to 
jejunum and ileum respectively. 1 cm samples were collected from the 
various intestinal sites. The 50% SI collection sample was, therefore, in 
the middle of the clamped region that had undergone I/R and the 90% 
site was outside of the previously clamped region. Kidney, liver and lung 
tissue were also collected. All tissue harvested was split into two, half 
being snap frozen at − 80 ◦C for further analysis, and the other half 
immediately fixed in 10% neutral buffered formalin for histopatholog-
ical assessment. 
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2.4.3. Histopathological assessment 
Tissue was stained using hemotoxylin-eosin and scored in a blinded 
manner by two independent observers. The entire collected segments of 
intestine were assessed. Intestinal damage was assessed using the 
scoring method of Chiu et al (Chiu, McArdle, Brown, Scott, & Gurd, 
1970) on a scale of 0 (normal) to 5 (damaged severely). 0- Normal 
mucosa and villi; 1- Development of subepithelial Gruenhagen’s space at 
villus tips, often accompanied by capillary congestion; 2- Extension of 
subepithelial space with moderate lifting of epithelial layer from lamina 
propria; 3- Massive lifting down sides of villi, some denuded tips; 4- 
Denuded villi, with lamina propria and dilated capillaries exposed, 
increased cellularity of lamina propria may be seen; 5- Digestion and 
disintegration of the lamina propria, haemorrhage and ulceration. 
Lung damage was scored using the method of Koksel et al. (2005) on 
a scale of 0 (no damage) to 3 (severe damage). 0- no damage; 1- mild 
neutrophil leukocyte infiltration and mild-moderate interstitial 
congestion; 2- moderate neutrophil leukocyte infiltration, perivascular 
edema formation and disintegration of the pulmonary structure; 3- 
dense neutrophil leukocyte infiltration and absolute destruction of 
pulmonary structure. Results are expressed as mean ± SEM. 
2.4.4. Tissue processing for biochemical analysis. 
Samples were homogenised on ice, in ice cold 50 mM potassium 
phosphate buffer (pH 6.0) containing 0.5% hexadecyl trimethyl 
ammonium bromide (HTAB), freeze thawed three times and briefly 
sonicated. An aliquot of the lysate was stored at − 80 ◦C and the 
remainder centrifuged at 15,000 rpm for 20 min at 4 ◦C. Supernatants 
were collected and saved as cleared lysates. Total protein concentration 
of the lysates and cleared lysates was determined using a standard 
protein assay. 
2.4.5. Myeloperoxidase (MPO) and MDA assays 
MPO activity, used as a marker of neutrophilic infiltration, was 
measured as described previously (FitzGerald et al., 2004). Cleared tis-
sue lysate was incubated with O-dianisidine dihydrochloride (Sigma) 
and 0.0005% hydrogen peroxide and change in absorbance at 460 nm 
recorded using a spectrophotometer. One unit of MPO activity was 
defined as that consuming 1 nmol of peroxide per minute at 22 ◦C. Re-
sults are expressed as U/μg of total protein, mean ± SEM from triplicate 
wells. 
MDA levels were determined as a marker of lipid peroxidation from 
tissue lysates using the thiobarbituric acid method (Satoh, 1978). Re-
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Fig. 1. Effect of hypoxia-normoxia (H/ 
N) on cell viability and injury in pres-
ence and absence of ZnC. Cell viability 
using MTT assay (A, C) and cell damage 
measuring LDH activity (B, D) were 
determined for cells exposed to 4 h 
hypoxia (ischemia) and then returned 
to normoxia for 24 h (reperfusion). 
Values are expressed as percentage 
difference compared to cells incubated 
in serum free medium alone that were 
not exposed to H/N. A&B. Cells incu-
bated under normoxic conditions 
throughout (●), subjected to H/N alone 
(○) and incubated in various concen-
trations of ZnC (▴), 1 h prior to under-
going H/N. C& D) The effect of adding 
ZnC (▴) pre hypoxia, during hypoxia or 
post hypoxia was compared to cells 
exposed to H/N alone (○). Results 
shown are for Caco-2 cells, RIE1 and 
AGS cells gave similar results. Results 
expressed as mean ± SEM. ** signifies 
p < 0.01 vs normoxic throughout, $$ 
signifies p < 0.01 vs H/N alone.   
R.J. Playford and T. Marchbank                                                                                                                                                                                                            
Journal of Functional Foods 78 (2021) 104361
4
2.4.6. Blood processing for LPS and cytokines 
Blood was collected into EDTA-treated tubes and centrifuged for 
10 min at 3000 rpm. Plasma was collected and frozen until analyses. 
LPS, IL6, IL1β and TNFα were analysed by commercial Elisa’s (Anti-
bodies-online.com) as per manufacturer’s instructions 
2.5. Study 4. Mechanisms of action of ZnC in the in vitro and in vivo 
studies 
Having shown that ZnC reduced cell and organ damage in our in 
vitro and in vivo studies, samples from in vitro cell viability studies and 
whole animal I/R tissues were further analysed to examine ZnC’s 
possible modes of action. 
2.5.1. Cell apoptosis assays 
Active caspase-3 and active caspase-9 were determined using 
methods described previously (Davison et al., 2016), using commercial 
colorimetric assay kits (BF3100 and BF10100, R&D Systems). Concen-
trations of the anti-apoptotic protein Bcl2 and the pro-apoptotic protein 
Baxα were determined in the same cell lysates as used for caspase ana-
lyses, using Duoset Elisa kits (R&D Systems Europe Ltd). 
2.5.2. Measurements of HIF1α, VEGF, Hsp70 and ICAM-1 
HIF1α, VEGF, Hsp70 and ICAM1 concentration in the cleared cell 
lysates was determined using Duoset Elisa kits as per the manufacturer’s 
instructions (R&D Systems Europe). Hsp70 concentrations were deter-
mined using our previously published methods (Davison et al., 2016), 
with a Duoset Elisa kit (R&D Systems Europe). 
2.5.3. Tight junction proteins 
ZO1 and Claudin1 concentrations were determined using previously 
published methods (Davison et al., 2016), and standard ELISA kits (tight 
junction antibody samples pack 90–1200, Invitrogen) 
2.6. Statistical analysis 
All results are expressed as mean ± SEM. Statistics were performed 
using Graphpad Prism 8 version 8.3.1. Test for normality of data using 
Shapiro Wilks test showed equal variances between groups. Studies were 
analyzed using an ordinary one-way analysis of variance ANOVA. 
Comparisons between treatments was performed using a Tukey’s mul-
tiple comparison test. Significance was determined at P < 0.05. 
3. Results 
3.1. Study 1. Effect of ZnC on cell survival following hypoxia (ischemia)/ 
normoxia (reperfusion) (H/N) 
Results shown in figures are for Caco-2 cells, RIE1 and AGS cells gave 
similar results. 
1A: Dose response study: The addition of ZnC to cells not subjected to 
H/N did not affect MTT or LDH levels. Exposure of cells to H/N alone 
resulted in an approximate halving of cell viability (MTT values, 
Fig. 1A) and a threefold increase in LDH leakage (Fig. 1B). Addition 
of ZnC prior to H/N reduced cell death, with the most beneficial 
effect seen at 100 μM, reducing the fall in cell viability (MTT) and 
rise in LDH caused by H/N by about 50% (Fig. 1A&B). 
1B: Efficacy of ZnC given pre-, during- or post-hypoxic period. When 
comparing the effect of ZnC (100 μM) administered pre-hypoxia, 
during hypoxia or post-hypoxia (at the reintroduction of normoxia 
stage), the greatest efficacy was seen if ZnC was given pre-hypoxia 
(Fig. 1C). Similar reciprocal changes were seen following changes 
in LDH (Fig. 1D). In contrast to the beneficial effect of adding ZnC, 
equimolar amounts of ZnSO4 alone, carnosine alone or 
ZnSO4 + carnosine in combination had no effect on H/N induced cell 
death or damage (Fig. 2A & B). 
3.2. Study 2. Effect of ZnC on TEER and transepithelial permeability 
The presence of ZnC given prior to H/N had no effect on TEER or 
HRP permeability under normoxic conditions. In monolayers subjected 
to H/N in the absence of ZnC, TEER fell to 81.3 ± 0.28% of baseline 
normoxic values at the end of the hypoxia period and fell further to 
64.5 ± 0.4% of baseline normoxic values at the end of the “reperfusion” 
(return to normoxia) period. Pre-treatment with ZnC truncated this 
decrease in TEER by about 50% (Fig. 3A). 
Similar reciprocal results were seen following permeability of HRP 
across monolayers. Control cells in serum free medium alone had a 4- 
fold increase in HRP permeability immediately after the hypoxic 








































































































































































Fig. 2. Effect of hypoxia-normoxia (H/N) on cell viability and injury in pres-
ence and absence of ZnSO4, carnosine alone and ZnSO4 + carnosine. Cell 
viability using MTT assay (A) and cell damage measuring LDH activity (B) were 
determined for cells exposed to 4 h hypoxia (ischemia) and then returned to 
normoxia for 24 h (reperfusion). Values are expressed as percentage difference 
compared to cells incubated in serum free medium alone that were not exposed 
to H/N. Cells incubated under normoxic conditions throughout (●), and the 
effect of adding ZnC (▴), ZnSO4 alone (Δ), carnosine alone (□) and 
ZnSO4 + carnosine in combination (◇), pre hypoxia, during hypoxia or post 
hypoxia was compared to cells exposed to H/N alone (○). Results shown are for 
Caco-2 cells, RIE1 and AGS cells gave similar results. Results expressed as 
mean ± SEM. ** signifies p < 0.01 vs normoxic throughout, $$ signifies 
p < 0.01 vs H/N alone. 
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treatment with ZnC truncated the rise in HRP permeability by 24% at the 
end of the hypoxic period and by 20% at the final H/N time point 
(Fig. 3B). In contrast, addition of equimolar amounts of ZnSO4 alone, 
carnosine alone or ZnSO4 and carnosine together did not influence 
changes in TEER (Fig. 3A) or HRP permeability (Fig. 3B) caused by H/N. 
3.3. Study 3. Effect of ZnC on gut and distant organ injury in response to 
small intestinal I/R 
Histological damage and MPO and MDA tissue levels: 
Intestinal tissue from 50% SI region of sham operated control ani-
mals showed normal histology (Fig. 4A), whereas the same region of 
animals that had undergone I/R showed extensive denudation and loss 
of villus structure and inflammatory infiltration (Fig. 4B). In contrast, 
animals that had received ZnC prior to I/R showed much less extensive 
damage (Fig. 4C). Tissue from the 90% SI length (not directly subjected 
to I/R) appeared histologically normal in all groups. 
Lung tissue from sham operated control animals had normal histol-
ogy or occasional mild increase in inflammatory infiltrate (Fig. 5A), 
whereas the I/R group showed marked pulmonary congestion and 
diffuse interstitial inflammatory cell infiltrate and areas of tissue 
destruction (Fig. 5B). ZnC pre-administration markedly truncated these 
effects (Fig. 5C). 
Formal histological damage scoring using methods of Chiu (Chiu 
et al., 1970) for SI damage (Fig. 4D) and Koksel (Koksel et al., 2005) for 
lung damage (Fig. 5D) confirmed histological appearance. Pre-treatment 
with ZnC reduced the intestinal injury score at the 50% SI site and within 
the lungs by approx. 60% (all p < 0.01 vs I/R alone). Similar results were 
seen when MPO & MDA levels were assessed (Table 1). In both 50% SI 
and lung, MPO & MDA levels were increased in response to I/R and this 
increase was truncated in animals pre-treated with ZnC. Assessment of 
tissue from the 90% SI site (not directly subjected to I/R) showed no 
changes in MPO or MDA following I/R compared to sham operated 
animals (Table S1). 
Histological examination of renal and liver tissue showed minimal 
changes, although biochemical assessment showed a small but signifi-
cant increase in both MDA and MPO levels following I/R. These 
biochemical changes were truncated in animals that received ZnC pre- 
treatment (Table 1). 
3.3.1. Plasma cytokine levels 
Exposure of animals to I/R caused plasma LPS to increase about 2- 
fold and plasma IL6, TNFα and IL1β levels to increase about four to 
five-fold compared to sham operated animals. These increases were all 
truncated by about 50–70% if the animals had received ZnC pre- 
treatment (Fig. 6). 
3.4. Study 4. Mechanisms of action of ZnC in the in vitro and in vivo 
studies 
Results from N/H studies using cell culture and mouse mesenteric I/ 
R tissue gave similar results (Fig. 7, Table 1, and Table S2) and are 
therefore discussed together. 
Subjecting cells or 50% SI tissue to periods of hypoxia/ischemia 
followed by normoxia/ reperfusion caused:  
• Increased pro-apoptotic molecules Caspase 3 & 9  
• Increased pro-apoptotic Baxα  
• Reduced anti-apoptotic peptide Bcl2  
• Reduced tight junction proteins ZO1 and Claudin 1  
• Increased cell adhesion molecule ICAM-1 (Table 1)  
• Increased HIF1α & VEGF 
Subjecting animals to mesenteric I/R also caused increased Hsp70 
and ICAM-1 expression in the lung tissue (Table 1). In the same animals, 
no changes were seen in Caspase 3, 9, Bcl2 or Baxα in the lung, kidney, 
liver or in the non-clamped SI region (90% SI, Table S1). 
ZnC pre-treatment of cells or animals caused:  
• Truncation of rise of pro-apoptotic molecules Caspase 3 & 9  
• Truncation of rise of pro-apoptotic Baxα  
• Truncation of fall in anti-apoptotic peptide Bcl2 
Fig. 3. Effect of ZnC on H/N- induced changes in TEER and transepithelial 
permeability. Polarised Caco-2 monolayers were exposed to H/N and the effect 
of ZnC on changes in TEER (A) and permeation of HRP through the monolayer 
(B) determined. Each monolayer had TEER and HRP permeability assessed at 
baseline (“normoxic”), at the end of 1 h incubation in a hypoxic chamber (“post 
hypoxia”) and at the end of a 24 h period where they had been returned to 
normoxia, equivalent to a reperfusion period (“post reperfusion”). Monolayers 
incubated in serum free medium alone (●, brown line) had significantly greater 
increases in permeability compared to those that had ZnC (100 μmol▴, black 
line) added to the medium prior to H/N. Addition of equimolar (100 μmol) 
ZnSO4 alone (Δ, red line), carnosine alone (□, green line) and ZnSO4 + car-
nosine in combination (∇, yellow line) had no effect on H/N induced changes 
(results overlapping with values seen from incubation in medium alone). For 
both TEER and HRP permeability all samples and time points were significantly 
different from baseline normoxia values. Results expressed as mean ± SEM but 
note that SEMs are small and overlap with symbols. ** signifies p < 0.01 vs 
values seen in cells incubated in medium alone under the same conditions of 
hypoxia-reperfusion. 
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• Truncation of fall in tight junction proteins ZO1 and Claudin 1  
• Did not affect the increase in cell adhesion molecule ICAM-1  
• Caused further increase in VEGF.  
• Caused further increase in Hsp70 
4. Discussion 
Using a combination of in vitro and in vivo models we showed that 
ZnC reduced I/R-induced gut injury. The protective pathways stimu-
lated in response to oral ZnC reduced I/R-induced apoptosis, increased 
cellular protective proteins such as Hsp70 and enhanced tight junction 
structure. The protective effect of ZnC were seen in all three cell lines 
tested. This demonstrates our findings have applicability across the 
entire gastrointestinal tract and are not species dependent, although 
caution always must be shown when extrapolating from in vitro cancer 
cell lines to the human in vivo situation. Some of the pathophysiological 
processes that occur due to I/R are mucosal epithelial cell damage, 
increased apoptosis, loss of basement membrane integrity and disrup-
tion of barrier function. This promotes bacterial and luminal content 
translocation with induction of local production of cytokines, resulting 
in chronic low-grade systemic inflammation and episodes of septicaemia 
(Eltzschig & Collard, 2004; Stallion et al., 2005) Our results examining 
changes in cell survival and transepithelial resistance in response to ZnC 
showed positive effects on these processes. We also found the macro-
molecule ZnC was more effective than an equimolar dose of ZnSO4 
alone, carnosine alone or the combination. This may be due, in part, to 
physicochemical aspects of ZnC, an idea supported by the finding that 
orally administered ZnC adheres to ulcerative areas of the bowel more 
effectively than ZnSO4 or carnosine alone (Furuta et al., 1995). 
The zinc and carnosine components of ZnC both possess potential 
protective effects, with their relative importance varying dependent on 
the model being examined. Zinc is an essential trace element involved in 
numerous physiological functions including stimulating cell prolifera-
tion and reducing apoptosis through pathways including activation of 
MMPs and the ERK1/2 cascades (For review see Nuttall & Oteiza, 2012). 
Carnosine is abundant in skeletal muscle and possesses anti-glycation, 
anti-stress, antioxidant and hydroxyl radical scavenging activity (For 
detailed reviews see Boldyrev, Aldini, & Derave, 2013, Kawahara, 
Tanaka, & Kato-Negishi, 2018). 
Several different in vivo methods are available for inducing gut I/R, 
the majority involving temporary complete occlusion of mesenteric ar-
teries +/-veins (see ref Gonzalez, Moeser, & Blikslager, 2014). All have 
the limitation of being acute rather than chronic I/R injury. We chose 
segmental mesenteric occlusion as it allows easy identification of in-
testine outside of the I/R area that can be used as a control to differ-
entiate local versus systemically mediated injury. The most severe 
damage was in the intestinal segment that had undergone direct I/R and 
systemic injury was confirmed with raised plasma cytokine levels and 
lung, liver and kidney markers of injury. Pre-treatment with ZnC 
significantly reduced histological and biochemical markers of injury in 
blood, gut, lung, and kidney. 
Administration of ZnC reduced apoptosis (as measured by caspases) 
and increased anti-apoptotic signaling molecules. These effects were 
mediated locally as distant organs and non-clamped regions of bowel did 
not show any similar changes. HIF1α and VEGF expression reduces 
apoptosis, stimulates angiogenesis and causes immune modulation 
(Cummins, Keogh, Crean, & Taylor, 2016; Karhausen et al., 2004), 
suggesting that Hsp70, HIF1α and VEGF may all have relevance to the 
protective effects seen. 

































Fig. 4. Effect of ZnC pre-treatment on histology 
and damage score in SI following I/R. Mice un-
derwent a sham (laparotomy only) procedure or 
were subjected to 30 min mesenteric ischemia 
followed by 3 h of reperfusion (I/R). Some ani-
mals also received ZnC (58 mg/kg/day, in drink-
ing water for 7 days pre-I/R). Photomicrographs 
(original magnification 200X) of intestinal tissue 
from 50% SI region A) sham operated control 
animal, B) animal that had undergone I/R proto-
col, C) animal pre-treated with ZnC prior to I/R. 
D) Formal histological damage scoring used 
method of Chiu et al. (1970). ** signifies p < 0.01 
vs sham operated animals, $$ signifies p < 0.01 vs 
I/R alone.   
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endothelial transmigration. 
Its upregulation in the lungs resulting from gut I/R is thought be an 
important signalling mechanism involved in pulmonary leukocyte 
infiltration (Zhao, Montalto, Pfeiffer, Hao, & Stahl, 1985). ZnC admin-
istration did not affect ICAM levels post I/R, suggesting that the pul-
monary protective effects of ZnC must be through other processes, such 
as via the reduced circulating cytokines demonstrated. Intestinal 
epithelial tight junctions are multiprotein complexes that act as selective 
barriers. The truncation of falls in ZO1 and Claudin 1 caused by ZnC 
administration may have contributed to the enhanced integrity seen in 
the TEER and HRP permeability studies. ZnC has been shown to activate 
the Nrf2/HO-1 signalling pathway, which may reduce the expression of 
inflammatory mediators, such as NO and iNOS (Ooi, Chan, & Sharif, 
2017). In addition, ZnC has been shown to increase phosphorylation of 
Smad1, a signal-transducing molecule (Maeno et al., 2004) and activate 
the ERK1/2 cascade system causing multiple effects on transcription 
factors and scaffolding proteins (Lu & Xu, 2006; Orton et al., 2005). 
Chronic gastrointestinal ischemia/reperfusion (I/R) injury results 
from a variety of causes and in contrast to the acute I/R situation, 
diagnosis in adults is often delayed. When the underlying cause of I/R is 
vascular in origin, symptoms may include post-prandial abdominal pain, 
sometimes termed abdominal angina resulting from periods of relative 
ischemia followed by return to vascular sufficiency, exacerbating the I/R 
mediated injury. Periods of increased gut permeability may also result in 
septicemic episodes requiring antibiotics. In some cases, revasculariza-
tion deals with the primary cause but when surgical intervention is not 
possible, pharmacological options have limited value and include anti-
coagulation, proton pump inhibitors, vasodilators, antimicrobials and 
inflammatory modulators (Jiang et al., 2012; Kalogeris, Baines, Krenz, & 
Korthuis, 2016; Mensink et al., 2011). ZnC offers a novel approach 
working through mechanisms distinct from the current alternatives and 
can be administered orally, surviving passage through the gastrointes-
tinal tract. Previous clinical studies examining the effect of ZnC on gut 
integrity for conditions such as exercise induced hyperpermeability 
(Davison et al., 2016) have used a dose of 75 mg/day, which is within 
recommended daily allowances for zinc intake, limiting risks of side 
effects. 
In summary, our studies showed that orally administered ZnC pro-
tects gut and distant organs from mesenteric I/R-induced injury. ZnC 
may provide a novel approach to the prevention and treatment of a wide 
variety of gut conditions which have I/R as a component of their path-
ophysiology. Further studies including clinical trials appear warranted 
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Fig. 5. Effect of ZnC pre-treatment on histology and damage score in lung following I/R. Same protocol as Fig. 4. Photomicrographs (original magnification 200X) of 
lung tissue (A) sham operated control animal, (B) animal that had undergone I/R protocol, (C) animal pre-treated with ZnC prior to I/R. (D) Formal histological lung 
damage scoring used method of Koksel et al. (2005). ** signifies p < 0.01 vs sham operated animals, $$ signifies p < 0.01 vs I/R alone. 
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Fig. 6. Plasma LPS and cytokine levels in animals undergoing I/R. Same protocol as Fig. 4. Plasma was collected at the end of the I/R protocol for animals that 
received sham operation, I/R alone, or I/R with ZnC pre-treatment. LPS (A) and cytokine analyses, IL6 (B), TNFα (C) and IL1β (D). * and ** signifies p < 0.05 and 
p < 0.01 vs sham operated animals, $$ signifies p < 0.01 vs I/R alone. 
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Fig. 7. Molecular mechanisms of action of ZnC on mice SI undergoing I/R. Same protocol as Fig. 4. Cleared cell lysates were collected from the 50% SI site of animals 
that had received sham operation, I/R alone, or I/R with ZnC pre-treatment. These were analysed for changes in apoptotic molecules Caspase 3 (A), Caspase 9 (B), 
Baxα (C) and Bcl2 (D). HIF1α (E), VEGF (F). Tight junction molecules ZO1 (G) and Claudin1 (H) levels were also measured. * or ** signifies p < 0.05 and < 0.01 vs 
sham operated animals, $$ signifies p < 0.01 when comparing the effect of ZnC pre-treatment against animals that had undergone I/R alone. 
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